Additionally, Hu Y et al. has reported that KIF23 could not only be used as a prognostic indicator for EOC, but also had a positive correlation with immune checkpoint protein, suggesting that it can be performed as a potential target for cancer immunotherapy, which is consistent with the results of our study [70]. The gene discussed is KIF23; the disease is cancer.